Larimar Therapeutics, Inc.
LRMR
$3.58
-$0.31-7.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.40% | -13.88% | -38.72% | -30.70% | 111.38% |
| Total Receivables | -29.13% | 6.15% | 30.89% | -2.13% | 217.47% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -59.03% | -21.14% | 40.19% | 167.77% | 253.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -27.28% | -14.08% | -37.02% | -28.35% | 116.58% |
|
|
|||||
| Total Current Assets | -27.28% | -14.08% | -37.02% | -28.35% | 116.58% |
| Net Property, Plant & Equipment | -27.64% | -21.71% | -19.52% | -0.62% | -1.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.07% | -41.43% | -40.91% | -41.10% | -39.84% |
| Total Assets | -27.16% | -14.46% | -36.76% | -31.44% | 108.71% |
|
|
|||||
| Total Accounts Payable | 115.18% | 558.36% | 42.92% | 18.56% | 88.93% |
| Total Accrued Expenses | 180.16% | 142.14% | 23.80% | 85.82% | 182.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.25% | 12.18% | 13.81% | 32.85% | 26.64% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 166.03% | 177.04% | 25.97% | 72.37% | 156.22% |
|
|
|||||
| Total Current Liabilities | 166.03% | 177.04% | 25.97% | 72.37% | 156.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.99% | -26.29% | -24.29% | -16.59% | -13.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 138.47% | 134.29% | 16.99% | 49.21% | 99.88% |
|
|
|||||
| Common Stock & APIC | 16.34% | 16.64% | 1.85% | 1.98% | 63.15% |
| Retained Earnings | -61.55% | -54.92% | -44.38% | -46.86% | -42.75% |
| Treasury Stock & Other | -63.51% | -81.56% | 94.00% | 316.00% | 82.72% |
| Total Common Equity | -54.55% | -29.92% | -43.31% | -37.50% | 110.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -54.55% | -29.92% | -43.31% | -37.50% | 110.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.55% | -29.92% | -43.31% | -37.50% | 110.24% |
|
|
|||||